<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas - Dhawan, S - 2020 | Cochrane Library</title> <meta content="Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas - Dhawan, S - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009229.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas - Dhawan, S - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009229.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009229.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas" name="citation_title"/> <meta content="Sanjay Dhawan" name="citation_author"/> <meta content="University of Minnesota" name="citation_author_institution"/> <meta content="Chirag G Patil" name="citation_author"/> <meta content="Maxine Dunitz Neurosurgical Institute" name="citation_author_institution"/> <meta content="Clark Chen" name="citation_author"/> <meta content="University of Minnesota" name="citation_author_institution"/> <meta content="Andrew S Venteicher" name="citation_author"/> <meta content="University of Minnesota" name="citation_author_institution"/> <meta content="aventeic@umn.edu" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD009229.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/01/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009229.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009229.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009229.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Brain Neoplasms [mortality, *radiotherapy, surgery]; Disease‐Free Survival; Glioma [*radiotherapy, surgery]; Postoperative Care; Progression‐Free Survival; Radiosurgery; Radiotherapy [methods]; Randomized Controlled Trials as Topic; Time Factors; Watchful Waiting" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009229.pub3&amp;doi=10.1002/14651858.CD009229.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="l7AWCCEw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009229\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009229\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","zh_HANS","zh_HANT","hr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009229.pub3",title:"Early versus delayed postoperative radiotherapy for treatment of low\\u2010grade gliomas",firstPublishedDate:"Jan 20, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=l7AWCCEw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009229.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009229.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009229.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009229.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009229.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009229.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009229.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009229.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009229.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009229.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3517 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009229.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0094"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0063"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-sec-0088"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/appendices#CD009229-sec-0099"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/table_n/CD009229StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/table_n/CD009229StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#CD009229-cr-0002">Sanjay Dhawan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#CD009229-cr-0003">Chirag G Patil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#CD009229-cr-0004">Clark Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information#CD009229-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Andrew S Venteicher</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information/en#CD009229-sec-0110">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 January 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009229.pub3">https://doi.org/10.1002/14651858.CD009229.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009229-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009229-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009229-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009229-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009229-abs-0001" lang="en"> <section id="CD009229-sec-0001"> <h3 class="title" id="CD009229-sec-0001">Background</h3> <p>This is an update of the review originally published in 2011 and first updated in 2015. </p> <p>In most people with low‐grade gliomas (LGG), the primary treatment regimen remains a combination of surgery followed by postoperative radiotherapy. However, the optimal timing of radiotherapy is controversial. It is unclear whether to use radiotherapy in the early postoperative period, or whether radiotherapy should be delayed until tumour progression occurs. </p> </section> <section id="CD009229-sec-0002"> <h3 class="title" id="CD009229-sec-0002">Objectives</h3> <p>To assess the effects of early postoperative radiotherapy versus radiotherapy delayed until tumour progression for low‐grade intracranial gliomas in people who had initial biopsy or surgical resection. </p> </section> <section id="CD009229-sec-0003"> <h3 class="title" id="CD009229-sec-0003">Search methods</h3> <p>Original searches were run up to September 2014. An updated literature search from September 2014 through November 2019 was performed on the following electronic databases: the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 11), MEDLINE via Ovid (September 2014 to November week 2 2019), and Embase via Ovid (September 2014 to 2019 week 46) to identify trials for inclusion in this Cochrane review update. </p> </section> <section id="CD009229-sec-0004"> <h3 class="title" id="CD009229-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared early versus delayed radiotherapy following biopsy or surgical resection for the treatment of people with newly diagnosed intracranial LGG (astrocytoma, oligodendroglioma, mixed oligoastrocytoma, astroblastoma, xanthoastrocytoma, or ganglioglioma). Radiotherapy may include conformal external beam radiotherapy (EBRT) with linear accelerator or cobalt‐60 sources, intensity‐modulated radiotherapy (IMRT), or stereotactic radiosurgery (SRS). </p> </section> <section id="CD009229-sec-0005"> <h3 class="title" id="CD009229-sec-0005">Data collection and analysis</h3> <p>Three review authors independently assessed the trials for inclusion and risk of bias, and extracted study data. We resolved any differences between review authors by discussion. Adverse effects were also extracted from the study report. We performed meta‐analyses using a random‐effects model with inverse variance weighting. </p> </section> <section id="CD009229-sec-0006"> <h3 class="title" id="CD009229-sec-0006">Main results</h3> <p>We included one large, multi‐institutional, prospective RCT, involving 311 participants; the risk of bias in this study was unclear. This study found that early postoperative radiotherapy was associated with an increase in time to progression compared to observation (and delayed radiotherapy upon disease progression) for people with LGG but did not significantly improve overall survival (OS). The median progression‐free survival (PFS) was 5.3 years in the early radiotherapy group and 3.4 years in the delayed radiotherapy group (hazard ratio (HR) 0.59, 95% confidence interval (CI) 0.45 to 0.77; P &lt; 0.0001; 311 participants; 1 trial; low‐quality evidence). The median OS in the early radiotherapy group was 7.4 years, while the delayed radiotherapy group experienced a median overall survival of 7.2 years (HR 0.97, 95% CI 0.71 to 1.33; P = 0.872; 311 participants; 1 trial; low‐quality evidence). The total dose of radiotherapy given was 54 Gy; five fractions of 1.8 Gy per week were given for six weeks. Adverse effects following radiotherapy consisted of skin reactions, otitis media, mild headache, nausea, and vomiting<i>.</i> Rescue therapy was provided to 65% of the participants randomised to delayed radiotherapy. People in both cohorts who were free from tumour progression showed no differences in cognitive deficit, focal deficit, performance status, and headache after one year. However, participants randomised to the early radiotherapy group experienced significantly fewer seizures than participants in the delayed postoperative radiotherapy group at one year (25% versus 41%, P = 0.0329, respectively). </p> </section> <section id="CD009229-sec-0007"> <h3 class="title" id="CD009229-sec-0007">Authors' conclusions</h3> <p>Given the high risk of bias in the included study, the results of this analysis must be interpreted with caution. Early radiation therapy was associated with the following adverse effects: skin reactions, otitis media, mild headache, nausea, and vomiting. People with LGG who underwent early radiotherapy showed an increase in time to progression compared with people who were observed and had radiotherapy at the time of progression. There was no significant difference in overall survival between people who had early versus delayed radiotherapy; however, this finding may be due to the effectiveness of rescue therapy with radiation in the control arm. People who underwent early radiation had better seizure control at one year than people who underwent delayed radiation. There were no cases of radiation‐induced malignant transformation of LGG. However, it remained unclear whether there were differences in memory, executive function, cognitive function, or quality of life between the two groups since these measures were not evaluated. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009229-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009229-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009229-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009229-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009229-abs-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009229-abs-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009229-abs-0009">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009229-abs-0004" lang="en"> <h3>Are there any differences in survival between people with low‐grade glioma having early compared with delayed radiotherapy at the time of progression? </h3> <p><b>The issue</b><br/> Low‐grade gliomas (LGG) are brain tumours that predominantly affect young adults. They grow at slower rates and are typically associated with a favourable prognosis compared with high‐grade gliomas. One of the most common presenting symptoms of people with LGG are seizures. Although, there are no definitive guidelines on the management of LGGs, most people with LGGs are treated with a combination of surgery followed by radiotherapy. However, it is unclear whether to use radiotherapy in the early postoperative period, or to delay until the disease progresses. </p> <p><b>Aim of the review:</b><br/> We aimed to compare the timing of radiotherapy from early (the postoperative period) or whether it should be delayed until the disease (tumour) re‐occurs. </p> <p><b>What are the main findings?</b><br/> From the literature search in September 2014, we included one randomised controlled trial, involving 311 participants, that looked at early or delayed radiotherapy given at the time of disease progression in people with LGG. This study was well‐designed and reported useful data on survival, but did not include other clinically important information, such as functional independent survival (functional, or neurological impairment, or both) and quality of life. Therefore, we felt that the trial was of unclear quality. People who received early (soon after surgery) radiotherapy had a longer time until their disease progressed than people who only had radiotherapy once the disease had progressed. However, the people that were initially observed had similar survival to the people who had early radiotherapy. Quality of life measures such as memory, executive function, and cognitive deterioration differences were not evaluated in either group. The findings did not suggest that people who received early radiotherapy lived longer than those had delayed radiotherapy. However, people who had early radiotherapy had better control over their seizures than those who had delayed radiotherapy. The toxic effects of radiotherapy were rated as minimal in both groups using a grading system which measured severity and included skin reactions, ear inflammation, mild headache, nausea, and vomiting. </p> <p>Update searches in November 2019 found no new articles which met the inclusion criteria. No articles were considered eligible for inclusion in this review update. </p> <p><b>What are the conclusions?</b><br/> Based on the current evidence, the results should be interpreted with caution. It is unclear whether or not early radiotherapy is better than delayed radiotherapy because survival was the same in both groups. People who had early radiotherapy experienced longer periods of tumour remission compared with patients who had delayed radiotherapy. However, it is unclear if these people suffered increased rates of cognitive impairment, neuroendocrine dysfunction, or radiation necrosis compared with people who had delayed radiotherapy. Toxic effects of radiation were minimal in both groups and there were no cases of second malignancies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009229-sec-0094" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-sec-0094">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-sec-0138">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009229-sec-0094"></div> <h3 class="title" id="CD009229-sec-0095">Implications for practice</h3> <section id="CD009229-sec-0095"> <p>Given the high risk of bias in the included trial, the results of this analysis must be interpreted with caution. Early radiation therapy was associated with the following adverse effects: skin reactions, otitis media, mild headache, nausea, and vomiting. People with LGG who underwent early radiotherapy showed an increase in time to progression compared with people who were observed and had radiotherapy at the time of progression. There was no significant difference in OS between people who had early versus delayed radiotherapy; however, this finding may be due to the effectiveness of rescue therapy with radiation in the control arm. People who underwent early radiation had better seizure control at one year than people who underwent delayed radiation. There were no cases of radiation‐induced malignant transformation of LGG. However, it remains unclear whether there were differences in memory, executive function, or cognitive function between the two groups since QoL measures were not evaluated. </p> </section> <h3 class="title" id="CD009229-sec-0096">Implications for research</h3> <section id="CD009229-sec-0096"> <p>Future trials need to include a rigorous comparison of the QoL, cognitive performance, and functional status of people undergoing early versus delayed radiotherapy for LGG. These trials ideally would have long‐term follow‐up data to effectively monitor for significant neurocognitive side effects of intracranial radiotherapy in people with LGG. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009229-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009229-sec-0022"></div> <div class="table" id="CD009229-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People with supratentorial and histologically proven low‐grade astrocytoma (including incompletely resected grade I pilocytic astrocytomas); WHO performance status 0 to 2 or Karnofski performance of 60 or more; age between 16 and 65 years; no other significant systemic diseases or malignancies interfering with follow‐up; not pregnant. Note: People with completely resected small grade I tumours (pilocytic astrocytoma), optic nerve glioma, brainstem glioma, and third ventricular gliomas were ineligible. </p> <p><b>Settings:</b> Between March 1986 and September 1997, eligible participants from the inpatient or outpatient settings from 24 institutions across Europe randomly allocated to intervention or control group </p> <p><b>Intervention:</b> Early radiotherapy </p> <p><b>Comparison:</b> Delayed radiotherapy at the time of recurrence </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Illustrative comparative risks</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (trials)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> <p>Median 7.8 years follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.97</b> (0.71 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311<br/> (1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕<sup>1</sup><br/> <b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the way HRs are calculated, the assumed and corresponding risks were not estimated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> <p>Median 7.8 years follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.59</b> (0.45 to 0.77) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311<br/> (1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕<sup>1</sup><br/> <b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the way HRs are calculated, the assumed and corresponding risks were not estimated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the quality of evidence to low from moderate (from the initial draft) after more careful assessment of the risk of bias in Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. Specifically, we felt that the lack of allocation concealment, blinding of participants and blinding of outcome assessment introduced sufficient bias to skew the true effects of early versus delayed postoperative radiation therapy on survival and progression‐free survival. These biases raise concerns about the precision and accuracy of the point estimates and associated CIs used to report the primary outcomes. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009229-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-sec-0118">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009229-sec-0023"></div> <section id="CD009229-sec-0024"> <h3 class="title" id="CD009229-sec-0024">Description of the condition</h3> <p>This is an update of the review originally published in 2011 (<a href="./references#CD009229-bbs2-0096" title="VenteicherAS , PatilCG . Early versus delayed radiotherapy for the treatment of low‐grade gliomas. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009229] ">Venteicher 2011</a>), and updated in 2015 (<a href="./references#CD009229-bbs2-0096" title="VenteicherAS , PatilCG . Early versus delayed radiotherapy for the treatment of low‐grade gliomas. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009229] ">Venteicher 2011</a>). </p> <p>Low‐grade gliomas (LGG) comprise a group of uncommon, progressive, and slow‐growing central nervous system (CNS) tumours that affect approximately 3000 and 9000 people per year in the USA and Europe, respectively, and account for 20% of all gliomas (<a href="./references#CD009229-bbs2-0068" title="OstromQT , GittlemanH , LiaoP , RouseC , ChenY , DowlingJ , et al. Primary brain and central nervous system tumors diagnosed in the United States 2007‐2011. CBTRUS Statistical Report. Neuro‐Oncology2014;14(suppl 4):iv1‐3. ">Ostrom 2014</a>; <a href="./references#CD009229-bbs2-0073" title="Surveillence of Rare Cancers in Europe. RARECARE database. www.rarecare.eu (accessed 26 June 2011). ">RARECARE 2011</a>). The incidence of LGG peaks in adulthood, with increased prevalence among whites and men (<a href="./references#CD009229-bbs2-0068" title="OstromQT , GittlemanH , LiaoP , RouseC , ChenY , DowlingJ , et al. Primary brain and central nervous system tumors diagnosed in the United States 2007‐2011. CBTRUS Statistical Report. Neuro‐Oncology2014;14(suppl 4):iv1‐3. ">Ostrom 2014</a>). Compared to the quick pace of tumour progression in people with high‐grade glioma, those with LGG typically live with the disease for between five to 20 years. Mean overall survival (OS) ranges from three to six years, four to seven years, and nine to 12 years for three common types of LGG (astrocytoma, mixed oligoastrocytoma, and oligodendroglioma, respectively) (<a href="./references#CD009229-bbs2-0055" title="JaeckleKA , DeckerPA , BallmanKV , FlynnPJ , GianniniC , ScheithauerBW , et al. Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis. Journal of Neuro‐Oncology2011; Vol. 104, issue 1:253‐9. ">Jaeckle 2011</a>; <a href="./references#CD009229-bbs2-0067" title="OhgakiH , KleihuesP . Population‐based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology2005;64(6):479‐89. ">Ohgaki 2005</a>; <a href="./references#CD009229-bbs2-0082" title="ShawEG , ScheithauerBW , O'FallonJR . Supratentorial gliomas: a comparative study by grade and histologic type. Journal of Neuro‐Oncology1997;31(3):273‐8. ">Shaw 1997</a>). Median progression‐free survival (PFS) for people with LGG who were treated in the post‐temozolomide era was 22 months (<a href="./references#CD009229-bbs2-0072" title="QuinnJA , ReardonDA , FriedmanAH , RichJN , SampsonJH , ProvenzaleJM , et al. Phase II trial of temozolomide in patients with progressive low‐grade glioma. Journal of Clinical Oncology2003;21(4):646‐51. ">Quinn 2003</a>). In 45% to 74% of cases, LGG subsequently transforms into higher grade glioma (<a href="./references#CD009229-bbs2-0055" title="JaeckleKA , DeckerPA , BallmanKV , FlynnPJ , GianniniC , ScheithauerBW , et al. Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis. Journal of Neuro‐Oncology2011; Vol. 104, issue 1:253‐9. ">Jaeckle 2011</a>). Determining the optimal management of people with LGG, given their relatively long survival, has been a carefully studied topic that as yet remains controversial. </p> <p>Most people with LGG (approximately 80%) present with seizures (<a href="./references#CD009229-bbs2-0038" title="ChangEF , PottsMB , KelesGE , LambornKR , ChangSM , BarbaroNM , et al. Seizure characteristics and control following resection in 332 patients with low‐grade gliomas. Journal of Neurosurgery.2008;108(2):227‐35. ">Chang 2008a</a>). Other presentations include personality changes, headache, nausea, and lethargy (<a href="./references#CD009229-bbs2-0043" title="DeAngelisLM . Brain tumors. New England Journal of Medicine2001;344(2):114‐23. ">DeAngelis 2001</a>). Neurological symptoms largely reflect the location and size of the tumour. LGG commonly occupies frontal or temporal lobes, particularly the supplemental motor area and insula (<a href="./references#CD009229-bbs2-0047" title="DuffauH , CapelleL . Preferential brain locations of low‐grade gliomas. Cancer2004;100(12):2622‐6. ">Duffau 2004</a>). Gliomas have a predilection for growing along white matter tracts into adjacent territories and the contralateral hemisphere. Diagnosis suggested by computerised tomography (CT) or magnetic resonance imaging (MRI), typically as a non‐enhancing lesion with little mass effect or vasogenic edema, is confirmed by microscopic analysis of a surgical tissue sample. Pathology establishes two key characteristics: the grade and subtype. LGG include grade 1 and 2 gliomas as defined by the World Health Organization (WHO) classification scheme (<a href="./references#CD009229-bbs2-0062" title="LouisDN , OhgakiH , WiestlerOD , CaveneeWK . WHO Classification of Tumours of the Central Nervous System. 4th Edition. Vol. 1, Geneva: WHO Press, 2007. ">Louis 2007</a>). WHO grade 1 tumours, such as pilocytic astrocytomas, are amenable to surgical cure by gross total resection (GTR). In unfortunate cases, involvement of eloquent cortex or key vascular structures may limit the ability to obtain a GTR. WHO grade 2 tumours are not readily cured surgically; these include diffuse astrocytoma, oligodendroglioma, mixed oligoastrocytoma, xanthoastrocytoma, astroblastoma, and ganglioglioma. WHO grade 2 and incompletely resected WHO grade I tumours are often grouped together in clinical trials, as clinical course is protracted and multi‐modality therapies are usually required. </p> <p>Initial management is based on symptomatology. Since most present with seizures, anti‐epileptic drugs (AEDs) are often employed for early seizure control (<a href="./references#CD009229-bbs2-0084" title="SoffiettiR , BaumertBG , BelloL , VonDeimlingA , DuffauH , FrénayM , et al. Guidelines on management of low‐grade gliomas: report of an EFNS–EANO Task Force. European Journal of Neurology2010;17(9):1124‐33. ">Soffietti 2010</a>), but about half of these people are refractory to AEDs (<a href="./references#CD009229-bbs2-0038" title="ChangEF , PottsMB , KelesGE , LambornKR , ChangSM , BarbaroNM , et al. Seizure characteristics and control following resection in 332 patients with low‐grade gliomas. Journal of Neurosurgery.2008;108(2):227‐35. ">Chang 2008a</a>). For tumours displaying vasogenic edema (increased fluid in the extracellular space of the brain) on MRI, steroids are often given. In rarer cases, the tumour may cause obstructive hydrocephalus (abnormal increase in the intracranial volume of cerebrospinal fluid resulting from obstruction of cerebrospinal fluid pathways in the ventricular system or subarachnoid space) or increased intracranial pressure necessitating decompressive or drainage manoeuvers. Once these initial measures are taken, the patient is then considered for further management based on prognostic factors such as the patient's age, symptoms, mental and performance status, location and size of tumour, involvement of eloquent cortex, contrast enhancement on MRI, and histologic/genetic aberrations of the tumour (<a href="./references#CD009229-bbs2-0039" title="ChangEF , SmithJS , ChangSM , LambornKR , PradosMD , ButowskiN , et al. Preoperative prognostic classification system for hemispheric low‐grade gliomas in adults. Journal of Neurosurgery2008;109(5):817‐24. ">Chang 2008b</a>; <a href="./references#CD009229-bbs2-0006" title="DanielsTB , BrownPD , FeltenSJ , WuW , BucknerJC , ArusellRM , et al. Validation of EORTC prognostic factors for adults with low‐grade glioma: a report utilizing intergroup 86‐72‐51. International Journal of Oncology, Biology, Physics2011;81(1):218‐24. ">Daniels 2011</a>; <a href="./references#CD009229-bbs2-0061" title="LoteK , EgelandT , HagerB , StenwigB , SkullerudK , Berg‐JohnsenJ , et al. Survival, prognostic factors, and therapeutic efficacy in low‐grade glioma: a retrospective study in 379 patients. Journal of Clinical Oncology1997;15(9):3129‐40. ">Lote 1997</a>; <a href="./references#CD009229-bbs2-0070" title="PignattiF , Van denBentM , CurranD , DebruyneC , SylvesterR , TherasseP , et al. European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group, European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group. Prognostic factors for survival in adult patients with cerebral low‐grade glioma. Journal of Clinical Oncology2002;20(8):2076‐84. ">Pignatti 2002</a>; <a href="./references#CD009229-bbs2-0079" title="ScerratiM , RoselliR , IacoangeliM , PompucciA , RossiGF . Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. Journal of Neurology, Neurosurgery, and Psychiatry1996;61(3):291‐6. ">Scerrati 1996</a>; <a href="./references#CD009229-bbs2-0080" title="SchiffD , BrownPD , GianniniC . Outcome in adult low‐grade glioma: the impact of prognostic factors and treatment. Neurology2007;69(13):1366‐73. ">Schiff 2007</a>; <a href="./references#CD009229-bbs2-0093" title="YehSA , HoJT , LuiCC , HuangYJ , HsiungCY , HuangEY . Treatment outcomes and prognostic factors in patients with supratentorial low‐grade gliomas. British Journal of Radiology2005;78(927):230‐5. ">Yeh 2005</a>). </p> <p>Further management involves surgery, radiotherapy, chemotherapy, or a combination of these modalities. Surgery is first‐line therapy whose chief role is to provide tissue to confirm the diagnosis. In addition, a goal of achieving more extensive resection (over biopsy alone) is often favoured because, in retrospective analyses, it is associated with prolonged survival (<a href="./references#CD009229-bbs2-0040" title="ClausEB , HorlacherA , HsuL , SchwartzRB , Dello‐IaconoD , TalosF , et al. Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance. Cancer2005;103(6):1227‐33. ">Claus 2005</a>; <a href="./references#CD009229-bbs2-0059" title="KelesGE , LambornKR , BergerMS . Low‐grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. Journal of Neurosurgery2001;95(5):735‐45. ">Keles 2001</a>; <a href="./references#CD009229-bbs2-0063" title="McGirtMJ , ChaichanaKL , AttenelloFJ , WeingartJD , ThanK , BurgerPC , et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low‐grade gliomas. Neurosurgery2008;63(4):700‐7. ">McGirt 2008</a>; <a href="./references#CD009229-bbs2-0078" title="SanaiN , BergerMS . Glioma extent of resection and its impact on patient outcome. Neurosurgery2008;62(4):753‐64. ">Sanai 2008</a>; <a href="./references#CD009229-bbs2-0081" title="SchomasDA , LaackNN , RaoRD , MeyerFB , ShawEG , O'NeillBP , et al. Intracranial low‐grade gliomas in adults: 30‐year experience with long‐term follow‐up at Mayo Clinic. Neuro‐Oncology2009;11(4):437‐45. ">Schomas 2009</a>; <a href="./references#CD009229-bbs2-0083" title="SmithJS , ChangEF , LambornKR , ChangSM , PradosMD , ChaS , et al. Role of extent of resection in the long‐term outcome of low‐grade hemispheric gliomas. Journal of Clinical Oncology2008;26(8):1338‐45. ">Smith 2008</a>; <a href="./references#CD009229-bbs2-0088" title="VanVeelenML , AvezaatCJ , KrosJM , VanPuttenW , VechtC . Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. Journal of Neurology, Neurosurgery, and Psychiatry1998;64(5):581‐7. ">Van Veelen 1998</a>), greater seizure control (<a href="./references#CD009229-bbs2-0038" title="ChangEF , PottsMB , KelesGE , LambornKR , ChangSM , BarbaroNM , et al. Seizure characteristics and control following resection in 332 patients with low‐grade gliomas. Journal of Neurosurgery.2008;108(2):227‐35. ">Chang 2008a</a>), and reduced risk of transformation to a higher grade (<a href="./references#CD009229-bbs2-0036" title="ChaichanaKL , McGirtMJ , LaterraJ , OliviA , Quiñones‐HinojosaA . Recurrence and malignant degeneration after resection of adult hemispheric low‐grade gliomas. Journal of Neurosurgery2010;112(1):10‐7. ">Chaichana 2010</a>; <a href="./references#CD009229-bbs2-0083" title="SmithJS , ChangEF , LambornKR , ChangSM , PradosMD , ChaS , et al. Role of extent of resection in the long‐term outcome of low‐grade hemispheric gliomas. Journal of Clinical Oncology2008;26(8):1338‐45. ">Smith 2008</a>). </p> <p>The next most common step in management is radiotherapy: either early radiotherapy (within a few weeks of surgery) or delayed radiotherapy (at time of clinical or imaging progression). Controversy exists on its optimal timing (<a href="./references#CD009229-bbs2-0037" title="ChanMD , TatterSB , LesserG , ShawEG . Radiation oncology in brain tumors: current approaches and clinical trials in progress. Neuroimaging Clinics of North America.2010;20(3):401‐8. ">Chan 2010</a>). Radiation induces apoptosis of mitotically active tumour cells (programmed cell death of actively dividing cancer cells), but also damages normal surrounding brain tissue. Radiation causes oedema from breakdown of the blood‐brain barrier, reactive gliosis (a non‐specific change of glial cells in response to damage to the CNS), and a general pro‐inflammatory state (<a href="./references#CD009229-bbs2-0060" title="KimJH , BrownSL , JenrowKA , RyuS . Mechanisms of radiation‐induced brain toxicity and implications for future clinical trials. Journal of Neuro‐Oncology2008;87(3):279‐86. ">Kim 2008</a>). Early adverse effects of radiation include headache, dizziness, ear inflammation, nausea, vomiting, seizure, altered level of consciousness, alopecia, dermatitis, urinary incontinence, and personality change (<a href="./references#CD009229-bbs2-0042" title="National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm2009, issue 4.0. ">CTCAE 2009</a>). Late clinical consequences of brain irradiation include leukoencephalopathy, neurocognitive decline, reduced quality of life (QoL), and tissue necrosis that may mimic tumour progression (<a href="./references#CD009229-bbs2-0046" title="DouwL , KleinM , FagelSS , Van denHeuvelJ , TaphoornMJ , AaronsonNK , et al. Cognitive and radiological effects of radiotherapy in patients with low‐grade glioma: long‐term follow‐up. Lancet Neurology2009;8(9):810‐8. ">Douw 2009</a>; <a href="./references#CD009229-bbs2-0085" title="Surma‐ahoO , NiemeläM , VilkkiJ , KouriM , BranderA , SalonenO , et al. Adverse long‐term effects of brain radiotherapy in adult low‐grade glioma patients. Neurology2001;56(10):1285‐90. ">Surma‐aho 2001</a>). The toxic effects of radiotherapy must be carefully weighed against the benefits for tumour control, including an improvement of seizures (<a href="./references#CD009229-bbs2-0077" title="RudàR , MagliolaU , BerteroL , TrevisanE , BosaC , MantovaniC , et al. Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro‐Oncology2013;15(12):1739‐49. ">Rudà 2013</a>). </p> <p>Promising alternative therapeutic modalities include stereotactic radiosurgery (SRS) and chemotherapy. SRS can produce long‐term control with an acceptable toxicity profile (<a href="./references#CD009229-bbs2-0041" title="CombsSE , Schulz‐ErtnerD , ThilmannC , EdlerL , DebusJ . Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. International Journal of Radiation Oncology, Biology, Physics2005;62(3):797‐802. ">Combs 2005</a>; <a href="./references#CD009229-bbs2-0050" title="HeppnerPA , SheehanJP , SteinerLE . Gamma knife surgery for low‐grade gliomas. Neurosurgery2005;57(6):1132‐9. ">Heppner 2005</a>; <a href="./references#CD009229-bbs2-0071" title="PlathowC , Schulz‐ErtnerD , ThilmanC , ZunaI , LichyM , WeberMA , et al. Fractionated stereotactic radiotherapy in low‐grade astrocytomas: long‐term outcome and prognostic factors. International Journal of Radiation Oncology, Biology, Physics2003;57(4):996‐1003. ">Plathow 2003</a>; <a href="./references#CD009229-bbs2-0089" title="WangLW , ShiauCY , ChungWY , WuHM , GuoWY , LiuKD , et al. Gamma Knife surgery for low‐grade astrocytomas: evaluation of long‐term outcome based on a 10‐year experience. Journal of Neurosurgery2006;105(Suppl):127‐32. ">Wang 2006</a>), and is generally reserved for inoperable tumours in close proximity to critical structures. Similarly, chemotherapy has potential either as a concurrent treatment or substitute for radiotherapy and can also improve seizure control (<a href="./references#CD009229-bbs2-0076" title="RudàR , BelloL , DuffauH , SoffiettiR . Seizure in low‐grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro‐Oncology2012;14(Suppl 4):iv55‐64. ">Rudà 2012</a>). Studies have focused primarily on a three‐drug regimen of procarbazine, lomustine, and vincristine (PCV) or single agent temozolomide. Ongoing randomised controlled trials (RCTs) are evaluating whether temozolomide can substitute for radiotherapy (<a href="./references#CD009229-bbs2-0049" title="EORTC‐22033‐26033‐ROG‐BTG . Primary chemotherapy with temozolomide versus radiotherapy in patients with low‐grade gliomas after stratification for genetic1p loss: a phase III study. www.eortc.be/protoc/details.asp?protocol=22033 (first received 12 July 2005). ">EORTC‐22033‐26033‐ROG‐BTG</a>), or whether concurrent temozolomide and radiotherapy is superior to radiotherapy alone for postoperative tumour control (<a href="./references#CD009229-bbs2-0066" title="NCT00978458ECOG‐E3F05 . Phase III randomized study of radiotherapy with versus without temozolomide in patients with symptomatic or progressive low‐grade gliomas. clinicaltrials.gov/ct2/results?cond=&amp;term=NCT00978458&amp;cntry=&amp;state=&amp;city=&amp;dist= (first received 17 September 2009). ">NCT00978458</a>; <a href="./references#CD009229-bbs2-0065" title="NCT00114140RTOG00424 . Phase II study of temozolomide and radiotherapy followed by temozolomide alone in patients with high‐risk low‐grade gliomas. clinicaltrials.gov/ct2/show/NCT00114140?term=NCT00114140&amp;draw=2&amp;rank=1 (first received 14 June 2005). ">NCT00114140</a>). While standard use of these alternative modalities await trial completion, the current primary effective treatment regimen remains a combination of surgery followed by radiotherapy. </p> </section> <section id="CD009229-sec-0025"> <h3 class="title" id="CD009229-sec-0025">Description of the intervention</h3> <p>The most common approach to people with LGG includes surgery (biopsy or resection) followed by either early (within a few weeks) or delayed (at the time of clinical progression) radiotherapy. Options for radiotherapeutic delivery exist, which include conformal EBRT, IMRT, and SRS. Each uses dedicated CT or MRI to guide dosimetry and planning, but vary in the technique used to specifically irradiate the tumour while minimising exposure of normal brain tissue. Sources for high‐energy photons include cobalt‐60 or a linear accelerator, with typical dosage in the 45 to 60 Gy range, delivered in 1.8 to 2.0 Gy fractions over a four‐ to eight‐week period. Standard radiation treatment fields target the tumour bed with a small (usually 2 cm) margin. Radiation produces double‐stranded DNA breaks and reactive oxygen species in the target tissue, resulting in damage to cycling cells of the tumour but also to normal brain tissue caught in the irradiated field. </p> </section> <section id="CD009229-sec-0026"> <h3 class="title" id="CD009229-sec-0026">How the intervention might work</h3> <p>The diffusely infiltrative nature of LGG makes even GTRs unlikely to be curative. Early radiotherapy is employed to arrest or kill any residual tumour cells, which may prolong time to tumour recurrence and increase survival. However, early radiotherapy will lead to earlier onset of late adverse effects of radiation, including neurocognitive decline and reduced QoL. In contrast, a strategy of delayed radiotherapy administered at time of tumour recurrence delays radiation exposure and its late adverse effects, but may allow tumour recurrence to occur more quickly. </p> </section> <section id="CD009229-sec-0027"> <h3 class="title" id="CD009229-sec-0027">Why it is important to do this review</h3> <p>A fundamental question in the management in LGG has been whether to use radiotherapy in the early postoperative period, or whether radiotherapy should be delayed until tumour progression occurs. Reasons why LGG has been difficult to study in large clinical trials include: (1) the diagnosis is uncommon requiring multi‐institution participation and longer enrolment times; and (2) people with LGG have long survival times requiring extensive follow‐up. Therefore, consolidating data from available trials through systematic review may provide sufficient power to generate new insights into this uncommon and controversial disease. In addition, in light of new treatment modalities becoming available on an ongoing basis, summarising the currently available literature will be important in the design of future clinical trials for people with LGG. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009229-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-sec-0123">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009229-sec-0028"></div> <p>To assess the effects of early postoperative radiotherapy versus radiotherapy delayed until tumour progression for low‐grade intracranial gliomas in people who had initial biopsy or surgical resection. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009229-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-sec-0029">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-sec-0124">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009229-sec-0029"></div> <section id="CD009229-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009229-sec-0031"> <h4 class="title">Types of studies</h4> <p>RCTs.</p> </section> <section id="CD009229-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included people who met the following criteria:</p> <p> <ul id="CD009229-list-0001"> <li> <p>Any age.</p> </li> <li> <p>Intracranial LGG.</p> </li> <li> <p>Histological types: astrocytoma, oligodendroglioma, mixed oligoastrocytoma, astroblastoma, xanthoastrocytoma, or ganglioglioma. This must be determined based on pathology review. </p> </li> <li> <p>Grade: WHO grade 2 or incompletely resected WHO grade 1. This must be determined based on pathology review. </p> </li> <li> <p>People will have undergone surgery, including: biopsy, partial resection (PR; less than 50%), subtotal resection (STR; 50 to 89%) or GTR (greater than 90%). This will be determined by either intra‐operative judgement or by radiologic evaluation by the patient's primary neurosurgical team. </p> </li> </ul> </p> <p>We excluded people documented as meeting any of the following criteria at time of trial entry: </p> <p> <ul id="CD009229-list-0002"> <li> <p>People who received previous cranial radiation.</p> </li> <li> <p>People who underwent craniotomy other than for biopsy or resection for the LGG.</p> </li> <li> <p>People who received previous chemotherapy.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We limited interventions to the comparison of early postoperative radiotherapy versus radiotherapy delayed until tumour progression following biopsy or surgical resection in LGG management. Radiotherapy may include conformal EBRT with linear accelerator or cobalt‐60 sources, IMRT, or SRS. In cases where glioma progression occurs following postoperative early or delayed radiotherapy, rescue therapy may involve a combination of repeat surgery, repeat radiotherapy, or chemotherapy and these cases were recorded. </p> </section> <section id="CD009229-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD009229-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009229-list-0003"> <li> <p>OS, defined as survival until death from all causes from time of randomisation.</p> </li> <li> <p>PFS, defined as survival until evidence of tumour recurrence is documented by CT or MRI scan. </p> </li> </ol> </p> <p>We defined recurrence according to <a href="http://www.iconplc.com/jp/our-services/imaging/central-imaging-core-lab-/regulatory-expertise/IMI-RANO-Critieria-Booklet-Nov-2011.pdf" target="_blank">Revised Assessment in Neuro‐Oncology</a> (RANO) criteria if data were available (see 'Local tumour control' in <a href="#CD009229-sec-0036">Secondary outcomes</a> and <a href="./appendices#CD009229-sec-0100">Appendix 1</a>). </p> </section> <section id="CD009229-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009229-list-0004"> <li> <p>Survival after progression (SAP), defined as survival after patient shows radiological evidence of tumour progression until death from all causes. Please refer to <a href="#CD009229-sec-0114">Differences between protocol and review</a>. </p> </li> <li> <p>Functionally independent survival (FIS), defined as: (1) a Karnofsky Performance Scale (KPS) score of ≥ 70% (<a href="./references#CD009229-bbs2-0057" title="KarnofskyDA , BurchenalJH . Evaluation of chemotherapeutic agents. In: MacleodCM editor(s). The Clinical Evaluation of Chemotherapeutic Agents in Cancer. New York: Columbia University Press, 1949:191‐205. ">Karnofsky 1949</a>; <a href="./references#CD009229-bbs2-0058" title="KarnofskyDA , BurchenalJH , ArmisteadGCJr , SouthamCM , BernsteinJL , CraverLF , et al. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen‐mustardlike activity suitable for oral and intravenous use. Archives of Internal Medicine1951;87(4):477‐516. ">Karnofsky 1951</a>); (2) Medical Research Council neurologic functional status (MRC‐NFS) score of one to two (<a href="./references#CD009229-bbs2-0064" title="MRC Working Party on Misonidazole in Gliomas. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. British Journal of Radiology1983;56(669):673‐82. ">MRC 1983</a>); or (3) WHO Performance Scale (WHO‐PS) score of zero to two (<a href="./references#CD009229-bbs2-0094" title="ZubrodCG , SchneidermanM , FreiEIII , BrindleyC , GoldGL , ShniderB , et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases1960;11(1):7‐33. ">Zubrod 1960</a>). These scales classify people according to functional, or neurological impairment, or both (see <a href="./appendices#CD009229-sec-0101">Appendix 2</a>). </p> </li> <li> <p>Disease‐specific survival (DSS), defined by survival until death due to neurological cause from time of randomisation. </p> </li> <li> <p>Steroid requirement, rated as worsened, unchanged, or improved.</p> </li> <li> <p>Seizure frequency, rated as increased, unchanged, or decreased.</p> </li> <li> <p>Local tumour control, rated by CT or MRI compared with baseline scan; based on RANO response criteria for LGG (<a href="./references#CD009229-bbs2-0087" title="Van denBentM , WefelJS , SchiffD , TaphoornM , JaeckleK , JunckL , et al. Response assessment in neuro‐oncology (a report of the RANO group): assessment of outcome in trials of diffuse low‐grade gliomas. Lancet Oncology2011;12(6):583‐93. ">Van den Bent 2011</a>) (see <a href="./appendices#CD009229-sec-0100">Appendix 1</a>). </p> </li> <li> <p>Cause of death.</p> </li> <li> <p>QoL, as measured using a scale validated through reporting of norms in a peer‐reviewed publication such as the European Organisation for Research and Treatment of Cancer (EORTC) Treatment of Cancer Quality of Life Questionnaire (QLQ‐C30) (<a href="./references#CD009229-bbs2-0033" title="AaronsonNK , AhmedzaiS , BergmanB , BullingerM , CullA , DuezNJ , et al. The European Organization for Research and Treatment of Cancer QLQ‐C30: a quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute.1993;85(5):365‐76. ">Aaronson 1993</a>), EORTC brain tumour module (QLQ‐BN20) (<a href="./references#CD009229-bbs2-0086" title="TaphoornMJ , ClaassensL , AaronsonNK , CoensC , MauerM , OsobaD , et al. EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. An international validation study of the EORTC brain cancer module (EORTC QLQ‐BN20) for assessing health‐related quality of life and symptoms in brain cancer patients. European Journal of Cancer2010;46(6):1033‐40. ">Taphoorn 2010</a>), Functional Assessment of Cancer Therapy: General (FACT‐G) or FACT‐ brain (FACT‐Br) (<a href="./references#CD009229-bbs2-0091" title="WeitznerMA , MeyersCA , GelkeCK , ByrneKS , CellaDF , LevinVA . The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors. Cancer1995;75(5):1151‐61. ">Weitzner 1995</a>), or the MD Anderson Symptom Inventory for brain tumour MDASI‐BT (<a href="./references#CD009229-bbs2-0034" title="ArmstrongTS , MendozaT , GningI , CocoC , CohenMZ , EriksenL , et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI‐BT). Journal of Neuro‐Oncology2006;80(1):27‐35. ">Armstrong 2006</a>). </p> </li> <li> <p>Adverse events caused by radiotherapy, which cannot be attributed to the tumour, as graded per the Common Terminology Criteria for Adverse Events (<a href="./references#CD009229-bbs2-0042" title="National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm2009, issue 4.0. ">CTCAE 2009</a>). Adverse events are graded on up to a five‐point scale outlined below. See <a href="./references#CD009229-bbs2-0042" title="National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm2009, issue 4.0. ">CTCAE 2009</a> for specific grading of each adverse event: </p> </li> </ol> <ul class="plain" id="CD009229-list-0005"> <li> <ul id="CD009229-list-0006"> <li> <p>Adverse events included the following: headache (graded one to three), dizziness (graded one to three), otitis/ear inflammation (graded one to five), nausea (graded one to three), depressed level of consciousness (graded one to five), seizure (graded one to five), personality change (graded one to five), CNS necrosis (graded one to five), CNS symptoms not otherwise specified (graded one to five), alopecia (graded one to two), dermatitis (graded one to five), and urinary incontinence (graded one to three). </p> <ul id="CD009229-list-0007"> <li> <p>Grade 1: 'mild' defined as asymptomatic or mild symptoms with no intervention necessary.</p> </li> <li> <p>Grade 2: 'moderate' defined as requiring only minimal, local, or non‐invasive intervention.</p> </li> <li> <p>Grade 3: 'severe' defined as disabling but not immediately life‐threatening requiring hospitalisation. </p> </li> <li> <p>Grade 4: 'life‐threatening' and requiring urgent intervention.</p> </li> <li> <p>Grade 5: 'death' related to adverse event(s).</p> </li> </ul> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD009229-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009229-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched, up to September 2014, the following electronic databases: the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 8) (<a href="./appendices#CD009229-sec-0105">Appendix 3</a>), MEDLINE (1948 to Aug week 3, 2014) (<a href="./appendices#CD009229-sec-0106">Appendix 4</a>), and Embase (1980 to Aug week 3, 2014) (<a href="./appendices#CD009229-sec-0107">Appendix 5</a>). All relevant articles were identified on PubMed and we carried out a further search for newly published articles using the 'related articles' feature. </p> <p>Update searches were run in November 2019 on the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 11), MEDLINE via Ovid (September 2014 to November week 2, 2019), and Embase via Ovid (September 2014 to 2019 week 46). </p> </section> <section id="CD009229-sec-0039"> <h4 class="title">Searching other resources</h4> <section id="CD009229-sec-0040"> <h5 class="title">Unpublished and grey literature</h5> <p>We searched the <a href="http://www.isrctn.com/page/mrct" target="_blank">MetaRegister of Controlled Trails</a> (MRCT), Physicians Data Query, <a href="http://www.controlled-trials.com/rct" target="_blank">www.controlled‐trials.com/rct</a>, <a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>, and <a href="http://www.cancer.gov/clinicaltrials" target="_blank">www.cancer.gov/clinicaltrials</a> for ongoing trials. We agreed a priori that if ongoing trials which had not been published were identified through these searches, we would contact the principal investigators to request any relevant data. We approached the major co‐operative trial groups active in this area in a similar manner. </p> <p>Conference proceedings and abstracts were searched through ZETOC (<a href="http://zetoc.mimas.ac.uk" target="_blank">http://zetoc.mimas.ac.uk</a>). </p> <p>We searched for theses and dissertations through WorldCat (<a href="http://firstsearch.oclc.org" target="_blank">http://firstsearch.oclc.org</a>).   </p> </section> <section id="CD009229-sec-0041"> <h5 class="title">Handsearching</h5> <p>We checked the reference lists of included studies, key textbooks, and previous systematic reviews by handsearching. Journal and conference materials over the past year were handsearched in the following sources: </p> <p> <ul id="CD009229-list-0008"> <li> <p>British Journal of Cancer.</p> </li> <li> <p>Neurosurgery.</p> </li> <li> <p>Annual Meeting of the American Society for Radiation Oncology (ASTRO).</p> </li> <li> <p>Annual Meeting of the American Association for Neurological Surgeons (AANS).</p> </li> <li> <p>Annual Meeting of European Society of Medical Oncology (ESMO).</p> </li> <li> <p>Annual Meeting of the American Society of Clinical Oncology (ASCO).</p> </li> </ul> </p> </section> <section id="CD009229-sec-0042"> <h5 class="title">Correspondence</h5> <p>We contacted the authors of relevant trials and experts at major hospitals performing clinical trials to identify further data which may or may not have been published. </p> </section> <section id="CD009229-sec-0043"> <h5 class="title">Language</h5> <p>We sought papers in all languages and performed translations, if necessary.</p> </section> </section> </section> <section id="CD009229-sec-0044"> <h3 class="title" id="CD009229-sec-0044">Data collection and analysis</h3> <section id="CD009229-sec-0045"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts retrieved by electronic searching to the reference management database Endnote (<a href="./references#CD009229-bbs2-0048" title="Thomson Reuters. ENDNOTE. Thomson Reuters, 2014. ">ENDNOTE 2014</a>). We removed duplicates and three review authors (AV, JMS, CP) independently examined the remaining references. The review authors were not blinded to the author(s) or affiliations of the studies. We excluded studies which clearly did not meet the inclusion criteria and obtained copies of the full text of potentially relevant references. Three review authors (AV, JMS, CP) independently assessed the eligibility of retrieved papers. We resolved disagreements by discussion between all review authors, and documented the reasons for exclusion of studies.  </p> </section> <section id="CD009229-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>For included studies, we extracted data as recommended in Chapter 7 (<a href="./references#CD009229-bbs2-0053" title="HigginsJPT , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>) of <a href="./references#CD009229-bbs2-0052" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>. This included data on the following: </p> <p> <ul id="CD009229-list-0009"> <li> <p>Author, year of publication and journal citation (including language).</p> </li> <li> <p>Country.</p> </li> <li> <p>Setting.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> <li> <p>Study design, methodology.</p> </li> <li> <p>Study population</p> <ul id="CD009229-list-0010"> <li> <p>total number enrolled</p> </li> <li> <p>patient characteristics</p> </li> <li> <p>age</p> </li> <li> <p>sex</p> </li> <li> <p>comorbidities</p> </li> <li> <p>previous treatment</p> </li> <li> <p>neurological performance.</p> </li> </ul> </li> </ul> <ul id="CD009229-list-0011"> <li> <p>Tumour details at diagnosis</p> <ul id="CD009229-list-0012"> <li> <p>tumour size</p> </li> <li> <p>tumour location</p> </li> <li> <p>tumour histology.</p> </li> </ul> </li> </ul> <ul id="CD009229-list-0013"> <li> <p>Intervention details</p> <ul id="CD009229-list-0014"> <li> <p>details of surgery</p> <ul id="CD009229-list-0015"> <li> <p>extent of biopsy/resection.</p> </li> </ul> </li> <li> <p>details of radiotherapy</p> <ul id="CD009229-list-0016"> <li> <p>type</p> </li> <li> <p>dose</p> </li> <li> <p>fractions</p> </li> <li> <p>time from surgery until radiotherapy</p> </li> <li> <p>tumour progression at the time of radiotherapy</p> </li> <li> <p>duration.</p> </li> </ul> </li> <li> <p>details of rescue therapy</p> <ul id="CD009229-list-0017"> <li> <p>surgery, chemotherapy and/or additional radiotherapy at the time of relapse.</p> </li> </ul> </li> </ul> </li> </ul> <ul id="CD009229-list-0018"> <li> <p>Risk of bias in study (<a href="#CD009229-sec-0047">Assessment of risk of bias in included studies</a>). </p> </li> <li> <p>Duration of follow‐up.</p> </li> <li> <p>Outcomes, which included OS, PFS, SAP, FIS, local tumour control, cause of death, steroid requirement, seizure frequency, DSS, adverse events, and QoL (<a href="#CD009229-sec-0034">Types of outcome measures</a>). </p> </li> </ul> </p> <p>We extracted data on outcomes as follows:</p> <p> <ul id="CD009229-list-0019"> <li> <p>For time‐to‐event data (e.g. OS, PFS, SAP, DSS and local tumour control rates), we extracted the log of the hazard ratio [log(HR)] and its standard error from trial reports; if these were not reported, we attempted to estimate them from other reported statistics using the methods of <a href="./references#CD009229-bbs2-0069" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>. If these variables could not be estimated, we reported available proportions with corresponding P values. </p> </li> <li> <p>For dichotomous outcomes (e.g. adverse events or deaths if it was not possible to use a HR), we extracted the number of participants in each treatment arm who experienced the outcome of interest and the number of participants assessed at endpoint, in order to estimate a risk ratio (RR). If these were not reported, we attempted to estimate them from other reported statistics. If these variables could not be estimated, we reported available proportions with corresponding P values. </p> </li> <li> <p>For continuous outcomes (e.g. QoL measures), we extracted the final value and standard deviation (SD) of the outcome of interest and the number of participants assessed at endpoint in each treatment arm at the end of follow‐up, in order to estimate the mean difference (MD) (if trials measured outcomes on the same scale) or standardised MDs (if trials measured outcomes on different scales) between treatment arms and its standard error. </p> </li> </ul> </p> <p>Where possible, all data extracted were those relevant to an intention‐to‐treat (ITT) analysis, in which participants are analysed in groups to which they are assigned. </p> <p>We noted the time points at which outcomes were collected and reported.</p> <p>Three review authors (AV, JMS, CP) extracted data independently onto a data extraction form specially designed for this Cochrane review. We resolved any differences between review authors by discussion. </p> </section> <section id="CD009229-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias in included RCTs using the following questions and criteria (see Chapter 8 (<a href="./references#CD009229-bbs2-0054" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>) of <a href="./references#CD009229-bbs2-0052" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>): </p> <section id="CD009229-sec-0048"> <h5 class="title">Sequence generation</h5> <p>Was the allocation sequence adequately generated?</p> <p> <ul id="CD009229-list-0020"> <li> <p>Low, e.g. a computer‐generated random sequence or a table of random numbers.</p> </li> <li> <p>High, e.g. date of birth, clinic ID‐number or surname.</p> </li> <li> <p>Unclear, e.g. not reported.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0049"> <h5 class="title">Allocation concealment</h5> <p>Was allocation adequately concealed?</p> <p> <ul id="CD009229-list-0021"> <li> <p>Low, e.g. where the allocation sequence could not be foretold.</p> </li> <li> <p>High, e.g. allocation sequence could be foretold by participants, investigators or treatment providers. </p> </li> <li> <p>Unclear, e.g. not reported.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0050"> <h5 class="title">Blinding</h5> <p>We restricted the assessment of blinding to blinding of outcome assessors, since it was not possible to blind participants and treatment providers to the different interventions. </p> <p>Was knowledge of the allocated interventions adequately prevented during the trial?</p> <p> <ul id="CD009229-list-0022"> <li> <p>Low.</p> </li> <li> <p>High.</p> </li> <li> <p>Unclear.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0051"> <h5 class="title">Performance bias</h5> <p>Was similar care provided to participants in treatment and control groups other than the intervention of interest? </p> <p> <ul id="CD009229-list-0023"> <li> <p>Low, e.g. the investigators followed both groups on similar schedules of neurologic exam and brain imaging. </p> </li> <li> <p>High, e.g. the investigators followed each group according to different schedules.</p> </li> <li> <p>Unclear, e.g. not reported.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0052"> <h5 class="title">Incomplete reporting of outcome data</h5> <p>We recorded the proportion of participants whose outcomes were not reported at the end of the trial. </p> <p>Were incomplete outcome data adequately addressed?</p> <p> <ul id="CD009229-list-0024"> <li> <p>Low, if &lt; 20% of participants were lost to follow‐up and reasons for loss to follow‐up were similar in both treatment arms. </p> </li> <li> <p>High, if &gt; 20% of participants were lost to follow‐up or reasons for loss to follow‐up differed between treatment arms. </p> </li> <li> <p>Unclear, if loss to follow‐up was not reported.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0053"> <h5 class="title">Selective reporting of outcomes</h5> <p>Were reports of the study free of suggestion of selective outcome reporting?</p> <p> <ul id="CD009229-list-0025"> <li> <p>Low, e.g. if review reported all outcomes specified in the protocol (<a href="./references#CD009229-bbs2-0096" title="VenteicherAS , PatilCG . Early versus delayed radiotherapy for the treatment of low‐grade gliomas. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009229] ">Venteicher 2011</a>). </p> </li> <li> <p>High, otherwise.</p> </li> <li> <p>Unclear, if insufficient information available.</p> </li> </ul> </p> </section> <section id="CD009229-sec-0054"> <h5 class="title">Other potential threats to validity</h5> <p>Was the study apparently free of other problems that could put it at a high risk of bias? </p> <p> <ul id="CD009229-list-0026"> <li> <p>Low.</p> </li> <li> <p>High.</p> </li> <li> <p>Unclear.</p> </li> </ul> </p> <p>Three review authors (AV, JMS, CP) independently applied the 'Risk of bias' tool and we resolved differences by discussion. We presented results in both a 'Risk of bias' graph and a 'Risk of bias' summary. We interpreted results of meta‐analyses in light of the findings with respect to risk of bias. </p> </section> </section> <section id="CD009229-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <p>We used the following measures of the effect of treatment:</p> <p> <ul id="CD009229-list-0027"> <li> <p>For time‐to‐event data, we used the HR, where possible.</p> </li> <li> <p>For dichotomous outcomes, we used the RR.</p> </li> <li> <p>For continuous outcomes, we used the MD between treatment arms or the standardised MD where outcomes were not measured on the same scale. </p> </li> </ul> </p> </section> <section id="CD009229-sec-0056"> <h4 class="title">Unit of analysis issues</h4> <p>Three review authors (AV, JMS, CP) reviewed unit of analysis issues according to <a href="./references#CD009229-bbs2-0052" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a> and we resolved differences by discussion. These included reports where: </p> <p> <ul id="CD009229-list-0028"> <li> <p>Groups of individuals were randomised together to the same intervention (i.e. cluster‐RCTs);</p> </li> <li> <p>Individuals underwent more than one intervention (e.g. in a cross‐over trial, or simultaneous treatment of multiple sites on each individual); or </p> </li> <li> <p>There were multiple observations for the same outcome (e.g. repeated measurements, recurring events, measurements on different body parts). </p> </li> </ul> </p> </section> <section id="CD009229-sec-0057"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing outcome data.</p> </section> <section id="CD009229-sec-0058"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between studies by visual inspection of forest plots, by estimation of the percentage of heterogeneity between studies which could not be ascribed to sampling variation (<a href="./references#CD009229-bbs2-0051" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>), and by a formal statistical test of the significance of the heterogeneity (<a href="./references#CD009229-bbs2-0044" title="DeeksJJ . Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ2001;323(7305):157‐62. ">Deeks 2001</a>). We investigated and reported possible reasons for heterogeneity In studies demonstrating evidence of substantial heterogeneity. Heterogeneity (I<sup>2</sup>) was defined according to the study by Higgins et al (<a href="./references#CD009229-bbs2-0051" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>) where I<sup>2</sup> values of 25%, 50% and 75% are categorised as low, moderate and high, respectively. </p> </section> <section id="CD009229-sec-0059"> <h4 class="title">Assessment of reporting biases</h4> <p>Three review authors (AV, JMS, CP) reviewed and recorded reporting biases.</p> </section> <section id="CD009229-sec-0060"> <h4 class="title">Data synthesis</h4> <p>If sufficient, clinically‐similar studies were available, we pooled the results in meta‐analyses. </p> <p> <ul id="CD009229-list-0029"> <li> <p>For time‐to‐event data, we pooled HRs using the generic inverse variance facility of <a href="./references#CD009229-bbs2-0074" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager (RevMan)</a>. </p> </li> <li> <p>For dichotomous outcomes, we calculated the RR for each study and then pooled the estimates.  </p> </li> <li> <p>For continuous outcomes, we pooled the MDs between the treatment arms at the end of follow‐up if all trials measured the outcome on the same scale, otherwise we pooled standardised mean differences (SMDs).  </p> </li> </ul> </p> <p>We used fixed‐effect models with inverse variance weighting for all meta‐analyses (<a href="./references#CD009229-bbs2-0045" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>). A random‐effects model was originally stated in the protocol; however, given that our meta‐analysis only included one study, we opted to use a fixed‐effect computational model to report a more descriptive analysis of the included study (<a href="./references#CD009229-bbs2-0035" title="BorensteinM , HedgesLV , HigginsJPT , RothsteinHR . Introduction to Meta‐Analysis. West Sussex: John Wiley &amp; Sons, Ltd, 2009. ">Borenstein 2009</a>)<b>.</b> </p> </section> <section id="CD009229-sec-0061"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We analysed outcome measures including OS, PFS, SAP, FIS, steroid requirement, seizure frequency, QoL, and adverse effects of radiotherapy after stratifying by the following clinical characteristics (if data were available): age, histologic subtype, tumour size and location, extent of resection, performance score, approach of radiotherapy used (conformal EBRT, IMRT, SRS), types of rescue therapy (repeat resection, repeat radiotherapy, chemotherapy), genetic aberrations (p53 status, 1p/19q status), and date of trial. </p> <p>We considered the following clinical factors during interpretation of any heterogeneity: age, tumour size, histologic subtype, definition used for 'tumour recurrence' and PFS, and length of follow‐up. </p> </section> <section id="CD009229-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>Two review authors (AV, CP) determined the requirement for sensitivity analysis and we resolved differences through discussion, according to <a href="./references#CD009229-bbs2-0052" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>. Sensitivity analysis for trial eligibility and analysis would be required if the search produced multiple trials with high risk of bias. This would indicate whether or not conclusions would have differed if eligibility was restricted to trials without high risk of bias for the outcome concerned. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009229-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009229-sec-0063"></div> <section id="CD009229-sec-0064"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD009229-sec-0116" title="">Characteristics of included studies</a>; <a href="./references#CD009229-sec-0117" title="">Characteristics of excluded studies</a>. </p> <section id="CD009229-sec-0065"> <h4 class="title">Results of the search</h4> <p>In the initial literature search in September 2014, We identified 1281 references in MEDLINE including Cancer‐Lit, 1683 in Embase and 539 in CENTRAL, giving a total of 3503 references. We did not find any additional studies from unpublished and grey literature, reference lists, or correspondence. There were 2333 unique references after we removed duplicates. Of these, we excluded 2323 after screening by title/abstract. We retrieved 10 full‐text articles, eight of which were excluded as they did not meet the intervention criteria. From the full‐text screening of the remaining two, it was noted that the reference by Karim in 2002 was the antecedent of the latest prospective RCT trial by <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. Since <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> refers to the long‐term efficacy of the primary trial by Karim 2002, it will henceforth be referred to as Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. We analysed the data from Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>, as this trial met our inclusion criteria and provided the most salient results to address our original question. We described Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> in the <a href="./references#CD009229-sec-0116" title="">Characteristics of included studies</a> section. The original trial by Karim 2002 is the earlier European Organisation for Research and Treatment of Cancer (EORTC) study of the <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> cohort that provided an interim analysis comparing early radiotherapy with delayed radiotherapy. The interim analysis provided minimal clinical significance compared with the long‐term results generated by <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. Please see <a href="#CD009229-fig-0001">Figure 1</a> for the PRISMA study flow diagram. </p> <div class="figure" id="CD009229-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram 2015." data-id="CD009229-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram 2015.</p> </div> </div> </div> <p>An updated literature search for the period from September 2014 through to November 2019 was performed on 18 November 2019. We identified 964 new records and 11 additional articles were identified by searching through the references in the identified records. After exclusion of duplicate articles, 959 articles were screened by title/abstract. Twenty‐four articles were selected for full‐text review. <a href="#CD009229-fig-0002">Figure 2</a> shows the study flow diagram for the review update. No new article met the inclusion criteria to be considered eligible for inclusion in this review update. </p> <div class="figure" id="CD009229-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram for 2020 update." data-id="CD009229-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram for 2020 update.</p> </div> </div> </div> </section> <section id="CD009229-sec-0066"> <h4 class="title">Included studies</h4> <p>One RCT met our inclusion criteria. Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> was a prospective, multi‐centre RCT that presented the long‐term results of a 1986 EORTC trial (Karim 2002) that compared early radiotherapy with delayed radiotherapy for people with LGGs. Participants from 24 participating institutions across Europe were randomly assigned to either early postoperative radiotherapy of 54 Gy in fractions of 1.8 Gy per week for six weeks or deferred radiotherapy until the time of progression (control group). Eligible participants had to have a histologically‐confirmed diagnosis of low‐grade astrocytoma, oligodendroglioma, mixed oligoastrocytoma, or incompletely resected pilocytic astrocytoma, with a WHO performance status of zero to two, or KPS of at least 60. In this trial, 154 people were assigned early radiotherapy and 157 people served as controls. There were 63 (41%) females in the early radiotherapy group and 52 (33%) in the control group. The median age of people who had early radiotherapy was 36.5 years, while those who had delayed radiotherapy had a median age of 41 years. The early radiotherapy group (5.3 years) had a statistically significantly higher median PFS compared with the control group (3.4 years) (P &lt; 0.0001), and there was a 20% improvement in five‐year PFS due to early radiotherapy (35% versus 55%). However, OS was similar between the two groups; the median survival in the early radiotherapy group was 7.4 years compared with 7.2 years in the control group (P = 0.872). The early radiotherapy group experienced slightly better performance status, as seizures were better controlled in this group. The trial authors did not assess participant's QoL or long‐term physical or cognitive changes. The median follow‐up time for all participants was 93 months. At the time of relapse, no further treatment at progression was given or documented for 13 (11.5%) participants in the control group and 32 (34%) participants in the early radiotherapy group. Salvage radiotherapy was given to 73 (65%) of participants in the control group and four (4%) of participants in the irradiated group. At the time of recurrence, chemotherapy was given to 18 (16%) participants in the control group and 35 (37%) participants who had early radiotherapy. </p> </section> <section id="CD009229-sec-0067"> <h4 class="title">Excluded studies</h4> <p>Of the 2333 unique references identified, we excluded 2323 as they did not meet the prespecified participant and outcome criteria. Eight studies were excluded as they did not meet the intervention criteria. For the review update, of the 959 unique references identified, we excluded 935 as they did not meet the prespecified participant and outcome criteria. Twenty four full‐text articles were excluded, please see the <a href="./references#CD009229-sec-0117" title="">Characteristics of excluded studies</a> section for the reasons for exclusion of these studies. </p> </section> </section> <section id="CD009229-sec-0068"> <h3 class="title">Risk of bias in included studies</h3> <p>The sole trial we evaluated, Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>, had an overall high risk of bias. We classified three out of seven criteria used to assess risk of bias as having unclear risk of bias, while the other four criteria had low risk of bias. Please see <a href="#CD009229-fig-0003">Figure 3</a> for the 'Risk of bias' graph and <a href="#CD009229-fig-0004">Figure 4</a> for the 'Risk of bias' summary. </p> <div class="figure" id="CD009229-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009229-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009229-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009229-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009229-sec-0069"> <h4 class="title">Allocation</h4> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> successfully randomised by stratification as various participant traits were distributed equally among both groups of participants, and "at baseline the treatment and control groups were not different with regard to sex, age, WHO performance status, MRC neurological function status, extent of surgery, histology, maximum diameter of the tumour, or whether the tumour crossed the midline". However, there was no statement of effort to conceal allocation. Since this was an unblinded trial, it is conceivable that post‐intervention management could affect survival and PFS. </p> </section> <section id="CD009229-sec-0070"> <h4 class="title">Blinding</h4> <p>Participants in the early radiotherapy and delayed radiotherapy groups could not be blinded to the results of the random allocation due to the study design. The study indicated that the ‘corresponding author had full access to all the data’ suggesting lack of concealment of the assigned treatment to the patient groups from the study authors. However, as far as the outcome assessment is concerned, it is not clear whether the treatment assignment was concealed from the investigators responsible for data interpretation. </p> </section> <section id="CD009229-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <p>Of the 311 participants randomised to either early or delayed radiotherapy in Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>, eight (2.6%) were ineligible for analysis due to incomplete data before entry to the trial, performance status greater than two or older than 65 years of age, and missing follow‐up data. Most participant characteristic variables (sex, age in years, WHO performance status, MRC‐NFS, extent of resection, histology, diameter, and tumour crossing the midline) had missing information, but these proportions were balanced across both groups. Despite random assignment to the control group, three participants received early radiotherapy (total dose of 50 to 54 Gy). These missing data are unlikely to influence the true effect of radiotherapy timing on outcomes for people with LGGs. </p> </section> <section id="CD009229-sec-0072"> <h4 class="title">Selective reporting</h4> <p>We reported all of Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>'s prespecified (primary) outcomes that were of interest in this Cochrane review in the prespecified way. This included OS and PFS, as well as the neurological signs and symptoms at one year in participants who were progression‐free at two years. </p> </section> <section id="CD009229-sec-0073"> <h4 class="title">Other potential sources of bias</h4> <section id="CD009229-sec-0074"> <h5 class="title">Random sequence generation and missing data (selection bias)</h5> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> randomised participants to treatments at the EORTC Data Center or the MRC Cancer Trials Office by use of a minimisation technique and stratification according to treatment institute, histology (astrocytoma versus oligodendroglioma or oligoastrocytoma), and extent of resection (biopsy versus partial, subtotal, or total). Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> had missing baseline characteristics in both groups of participants, which may potentially predispose the trial to selection bias. However, there was a balance in the distribution of missing baseline characteristics between both groups, minimising the likelihood that selection bias would affect one group over the other. </p> </section> <section id="CD009229-sec-0075"> <h5 class="title">Intervention/exposure bias</h5> <p>This trial also has the potential for intervention, or exposure, bias since the trial authors evaluated performance status based only upon tumour progression. The study authors conceded that "because the patients in the control group (those who received delayed radiotherapy) progressed earlier, there might be a bias in favour of the control group". However, they limited this possibility by performing a post hoc analysis on participants' neurological signs and symptoms at one year only in participants who were progression‐free at two years. This prevented any participant with an undetected progression at the one‐year mark from biasing the analysis. </p> </section> </section> </section> <section id="CD009229-sec-0076"> <h3 class="title" id="CD009229-sec-0076">Effects of interventions</h3> <p>See: <a href="./full#CD009229-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings table 1</a> </p> <p>All outcomes reported in this section are based on results from the multi‐institutional, prospective RCT by Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. </p> <section id="CD009229-sec-0077"> <h4 class="title">Overall survival</h4> <p>The difference in median OS between the group who received early radiotherapy and the group who received delayed radiotherapy was not statistically significant (7.2 versus 7.4 years, respectively, log‐rank P = 0.873; HR 0.97, 95% CI 0.71 to 1.33; <a href="#CD009229-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD009229-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.1 Overall survival." data-id="CD009229-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.1 Overall survival. </p> </div> </div> </div> </section> <section id="CD009229-sec-0078"> <h4 class="title">Progression‐free survival</h4> <p>People who were randomised to early radiotherapy demonstrated statistically significantly longer PFS than people randomised to delayed radiotherapy (5.3 versus 3.4 years, respectively, long‐rank P &lt; 0.0001; HR 0.59, 95% CI 0.45 to 0.77; <a href="#CD009229-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD009229-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.2 Progression‐free survival." data-id="CD009229-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.2 Progression‐free survival. </p> </div> </div> </div> </section> <section id="CD009229-sec-0079"> <h4 class="title">Survival after progression</h4> <p>SAP was 3.4 years for the delayed radiotherapy group versus 1.0 years for the early radiotherapy group (log‐rank P &lt; 0.0001). </p> </section> <section id="CD009229-sec-0080"> <h4 class="title">Functionally independent survival</h4> <p>One of the inclusion criteria of this trial required participants to have a WHO performance status of zero to two, or KPS of ≥ 60, and the trial authors documented WHO performance status and MRC‐NFS baseline characteristics in most participants at the time of randomisation. However, Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> did not report FIS outcomes in the form of WHO performance status, KPS, or MRC‐NFS. Instead, they investigated whether participants free from tumour progression had any neurological signs and symptoms by performing a post hoc analysis of participants' clinical examination at one year. They found "no differences between the two groups for cognitive deficit, focal deficit, performance status, and headache (data not shown)". </p> </section> <section id="CD009229-sec-0081"> <h4 class="title">Disease‐specific survival</h4> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> did not calculate DSS. </p> </section> <section id="CD009229-sec-0082"> <h4 class="title">Steroid requirement</h4> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> did not assess steroid requirements. </p> </section> <section id="CD009229-sec-0083"> <h4 class="title">Seizure frequency</h4> <p>At baseline, there were no differences between early and delayed radiotherapy groups in seizure control (P = 0.8701). However, at one year follow‐up, 26 of 102 (25%) participants who were irradiated had seizures compared with 29 of 71 (41%) participants who had not been irradiated (P = 0.0329). </p> </section> <section id="CD009229-sec-0084"> <h4 class="title">Local tumour control</h4> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> evaluated tumour progression by comparing follow‐up CT scans with the baseline scan; however, the investigators did not utilise the RANO response criteria for LGG. Among the 311 participants, 217 (70%) had progressed and 156 (50%) had died after follow‐up or a median time of 7.8 years. </p> </section> <section id="CD009229-sec-0085"> <h4 class="title">Cause of death</h4> <p>Among the 156 participants that died, 142 participants (91%) died from a progressive brain tumour, 12 participants (8%) died from unrelated causes, and no information on the cause of death was available for two participants (1%). </p> </section> <section id="CD009229-sec-0086"> <h4 class="title">Quality‐of‐life</h4> <p>Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> did not assess QoL. </p> </section> <section id="CD009229-sec-0087"> <h4 class="title">Adverse events</h4> <p>Adverse events were not classified according to <a href="./references#CD009229-bbs2-0042" title="National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm2009, issue 4.0. ">CTCAE 2009</a>. The trial authors indicated that "toxic effects were modest in general, and mainly consisted of skin reactions, otitis, mild headache, nausea, and vomiting. Irradiation was interrupted in six participants because of acute reactions". The trial did not report rates of cognitive impairment or rates of possible radiotherapy‐induced leucoencephalopathy. Their findings do not support the speculation that early radiotherapy might induce malignant transformation of LGG, as there was no difference in progression to a high‐grade tumour upon disease recurrence between both groups (statistical data not provided). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009229-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009229-sec-0088">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009229-sec-0132">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009229-sec-0088"></div> <section id="CD009229-sec-0089"> <h3 class="title" id="CD009229-sec-0089">Summary of main results</h3> <p>The large, multi‐institutional, prospective RCT of Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> demonstrated that early postoperative radiotherapy is associated with an increase in time to progression compared to observation (and delayed radiotherapy upon disease progression) for people with LGG but does not improve OS. The median PFS was 5.3 years in the early radiotherapy group and 3.4 years in the delayed radiotherapy group (HR 0.59, 95% confidence interval (CI) 0.45 to 0.77; P &lt; 0.0001). However, the median OS did not show a statistically significant difference between the groups. The median OS in the early radiotherapy group was 7.4 years, while the delayed radiotherapy group experienced a median OS of 7.2 years (HR 0.97, 95% CI 0.71 to 1.33; P = 0.872). </p> <p>The trial authors used stratified randomisation to equally distribute clinical prognostic factors, such as age, tumour size, functional status, and extent of resection, among both treatment groups. After a median follow‐up time of 7.8 years (93 months), approximately 70% of participants had progressed and 50% had died. Adverse effects were minimal; they mainly consisted of skin reactions, otitis media, mild headache, nausea, and vomiting. Participants in both cohorts who were free from tumour progression showed no differences in cognitive deficit, focal deficit, performance status, and headache. However, participants randomised to the early radiotherapy group experienced significantly fewer seizures than participants in the delayed radiotherapy group at one year follow‐up (25% versus 41%, P = 0.0329, respectively). </p> <p>Using an ITT analysis, 55% of participants irradiated early did not show any evidence of tumour progression at five years, compared with 35% of participants who had delayed radiotherapy. Also at five years, 68% of participants in the early radiotherapy group were alive compared with 66% of participants in the delayed radiotherapy group. They provided rescue therapy to 65% of the participants randomised to delayed radiotherapy and 4% of the participants randomised to early radiotherapy. This led to a median SAP of 3.4 years for participants with delayed radiotherapy and one year for the participants with early radiotherapy. The results from Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> indicate that the timing of radiotherapy is less important for prolonging survival provided it is given at some point during the treatment course and optimal rescue therapy can be readily provided for participants who undergo delayed radiotherapy. Notably, Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> did not investigate what type of long term QoL their participants experienced. Therefore, it is not known whether improved time to progression is associated with long‐term cognitive or neurological deterioration in participants with LGGs. </p> </section> <section id="CD009229-sec-0090"> <h3 class="title" id="CD009229-sec-0090">Overall completeness and applicability of evidence</h3> <p>The optimal treatment of LGG remains controversial, and current guidelines on the management of people with an alleged LGG are not based on established clinical evidence. We aimed to evaluate the fundamental question of whether to use radiotherapy in the early postoperative period, or whether radiotherapy should be delayed until tumour progression occurs. Our search yielded one large, multi‐institutional trial by Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> that sought to elucidate the optimal timing of radiotherapy in people with LGG who have good pre‐treatment functional status. This trial showed that early radiotherapy significantly improves PFS compared with observation and delayed radiotherapy until disease progression. However, there was no difference in OS between these two groups, mainly because most people who received delayed radiotherapy were also given some form of rescue therapy. The trial also analysed symptom burden in people who had no evidence of progression and showed that early radiotherapy improves seizure control better than delayed radiotherapy. However, the trial authors assessed tumour control using CT scan instead of MRI, and imaging methods were not guided by specific imaging parameters and endpoints. Furthermore, the trial authors did not adequately report adverse effects of radiotherapy and they did not evaluate people's postoperative functional status. The greatest limitation of this trial, however, is the lack of data on participant's QoL and cognitive function. Cognitive deterioration may eventually occur from deleterious effects of early radiotherapy or disease progression in people who opt for delayed radiotherapy. This trial affirms the efficacy of radiotherapy in the treatment of LGG, but the optimal time to give radiation therapy still remains unclear because the effect of early versus delayed radiotherapy on neurocognitive deterioration is not known. </p> </section> <section id="CD009229-sec-0091"> <h3 class="title" id="CD009229-sec-0091">Quality of the evidence</h3> <p>One large multi‐institutional RCT, Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>, forms the basis of our systematic review and its conclusions. Overall, we determined that this trial had a high risk of bias after careful evaluation of the criteria we used to assess risk of bias. Given this risk of bias, the results and conclusions of this Cochrane review must be interpreted in the context of this uncertainty. See <a href="#CD009229-fig-0003">Figure 3</a> for the 'Risk of bias' graph and <a href="#CD009229-fig-0004">Figure 4</a> for the 'Risk of bias' summary. The lack of allocation concealment, blinding of participants and blinding of outcome assessment introduces various types of biases that may conceivably skew the true effects of early versus delayed postoperative radiation therapy on survival and PFS. For these reasons, we attributed a low GRADE quality of evidence for the OS and PFS outcome parameters reported in Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. </p> <p>This large trial showed an increase in PFS after early radiotherapy versus delayed radiotherapy. Since most patients randomised to delayed radiotherapy received some form of rescue therapy at the time of disease progression, there was no significant difference in median OS between the two cohorts. The primary endpoints of this trial were PFS and OS, but the trial authors also assessed SAP, neurological symptoms at one year in people who had not shown evidence of disease progression, seizure frequency, and cause of death. Local tumour control was also included but was not assessed using the RANO response criteria for LGG. Adverse effects were briefly mentioned but they were not quantified or classified according to <a href="./references#CD009229-bbs2-0042" title="National Cancer Institute at the National Institutes of Health. Common terminology criteria for adverse events. ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm2009, issue 4.0. ">CTCAE 2009</a> standards. Other clinically important outcomes such as FIS, DSS, steroid requirement, and QoL were not evaluated. Hence, our systematic review's internal validity is limited since all of the results and conclusions are based on this single large RCT (Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>). </p> </section> <section id="CD009229-sec-0092"> <h3 class="title" id="CD009229-sec-0092">Potential biases in the review process</h3> <p>We performed a comprehensive search, including a thorough search of the grey literature. We screened all identified studies and three review authors independently extracted data. We restricted the included studies to RCTs as these provide the strongest level of evidence available. Hence, we have attempted to reduce bias in the review process. However, the greatest threat to the validity of the review is likely to be the possibility of publication bias, i.e. studies that did not find the treatment to have been effective may not have been published. </p> </section> <section id="CD009229-sec-0093"> <h3 class="title" id="CD009229-sec-0093">Agreements and disagreements with other studies or reviews</h3> <p>EORTC 22845 by Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a> is the only trial that investigated the role of radiation timing on survival for people with LGG. </p> <p>There are two randomised trials that investigated different radiation doses in the management of LGGs: <a href="./references#CD009229-bbs2-0056" title="KarimAB , MaatB , HatlevollR , MentenJ , RuttenEH , ThomasDG , et al. A randomized trial on dose‐response in radiation therapy of low‐grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. International Journal of Radiation Oncology, Biology, Physics1996;36(3):549‐56. ">Karim 1996</a> (EORTC 22844) and <a href="./references#CD009229-bbs2-0023" title="ShawE , ArusellR , ScheithauerB , O'FallonJ , O'NeillB , DinapoliR , et al. Prospective randomized trial of low‐ versus high‐dose radiation therapy in adults with supratentorial low‐grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. Journal of Clinical Oncology2002;20(9):2267‐76. ">Shaw 2002</a> (NCCTG). These trials provided class I evidence showing no advantage for higher versus lower radiation doses. </p> <p>Radiation therapy has been shown to improve seizure control in people with LGG. A retrospective study by <a href="./references#CD009229-bbs2-0090" title="WarnkePC , BerlisA , WeyerbrockA , OstertagCB . Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low‐grade gliomas. Acta Neurochirurgica1997;68(Suppl):90‐2. ">Warnke 1997</a> reported a seizure control rate of 79% using stereotactic interstitial radiosurgery at six months for people with LGG with medically refractory seizures. Conventional radiation can also reduce seizure frequency in people with LGG and medically refractory seizures (<a href="./references#CD009229-bbs2-0075" title="RogersLR , MorrisHH , LupicaK . Effect of cranial irradiation on seizure frequency in adults with low‐grade astrocytoma and medically intractable epilepsy. Neurology1993;43(8):1599‐1601. ">Rogers 1993</a>). </p> <p>One of the strongest arguments for delaying or withholding radiotherapy in people with LGG is the risk of radiotherapy‐induced leucoencephalopathy, which can result in cognitive dysfunction. <a href="./references#CD009229-bbs2-0046" title="DouwL , KleinM , FagelSS , Van denHeuvelJ , TaphoornMJ , AaronsonNK , et al. Cognitive and radiological effects of radiotherapy in patients with low‐grade glioma: long‐term follow‐up. Lancet Neurology2009;8(9):810‐8. ">Douw 2009</a> evaluated the cognitive status of 65 people with LGG who had neuropsychological follow‐up at a mean of 12 years and were free of tumour progression. People who received radiation therapy performed worse in measures of executive functioning, attentional functioning, and information processing speed compared with people who did not receive radiation therapy. However, it is uncertain whether early radiotherapy can postpone neurological deterioration. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009229-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram 2015." data-id="CD009229-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram 2015.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram for 2020 update." data-id="CD009229-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>PRISMA study flow diagram for 2020 update.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009229-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009229-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.1 Overall survival." data-id="CD009229-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.2 Progression‐free survival." data-id="CD009229-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early versus delayed radiotherapy, outcome: 1.2 Progression‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed radiotherapy, Outcome 1 Overall survival." data-id="CD009229-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed radiotherapy, Outcome 1 Overall survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references#CD009229-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009229-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/urn:x-wiley:14651858:media:CD009229:CD009229-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_t/tCD009229-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early versus delayed radiotherapy, Outcome 2 Progression‐free survival." data-id="CD009229-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Early versus delayed radiotherapy, Outcome 2 Progression‐free survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references#CD009229-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/media/CDSR/CD009229/image_n/nCD009229-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009229-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early versus delayed postoperative radiotherapy for treatment of low‐grade gliomas</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People with supratentorial and histologically proven low‐grade astrocytoma (including incompletely resected grade I pilocytic astrocytomas); WHO performance status 0 to 2 or Karnofski performance of 60 or more; age between 16 and 65 years; no other significant systemic diseases or malignancies interfering with follow‐up; not pregnant. Note: People with completely resected small grade I tumours (pilocytic astrocytoma), optic nerve glioma, brainstem glioma, and third ventricular gliomas were ineligible. </p> <p><b>Settings:</b> Between March 1986 and September 1997, eligible participants from the inpatient or outpatient settings from 24 institutions across Europe randomly allocated to intervention or control group </p> <p><b>Intervention:</b> Early radiotherapy </p> <p><b>Comparison:</b> Delayed radiotherapy at the time of recurrence </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Illustrative comparative risks</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (trials)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> <p>Median 7.8 years follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.97</b> (0.71 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311<br/> (1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕<sup>1</sup><br/> <b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the way HRs are calculated, the assumed and corresponding risks were not estimated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> <p>Median 7.8 years follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.59</b> (0.45 to 0.77) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311<br/> (1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕<sup>1</sup><br/> <b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the way HRs are calculated, the assumed and corresponding risks were not estimated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>HR:</b> hazard ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded the quality of evidence to low from moderate (from the initial draft) after more careful assessment of the risk of bias in Karim 2002: <a href="./references#CD009229-bbs2-0001" title="KarimABMF , AfraD , CornuP , BleehanN , SchraubS , DeWitteO , et al. Randomized trial on the efficacy of radiotherapy for cerebral low‐grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. International Journal of Radiation Oncology, Biology, Physics2002;52(2):316‐24. Van denBentMJ , AfraD , DeWitteO , Ben HasselM , SchraubS , Hoang‐XuanK , et al. Long‐term efficacy of early versus delayed radiotherapy for low‐grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366(9490):985‐90. ">Van den Bent 2005</a>. Specifically, we felt that the lack of allocation concealment, blinding of participants and blinding of outcome assessment introduced sufficient bias to skew the true effects of early versus delayed postoperative radiation therapy on survival and progression‐free survival. These biases raise concerns about the precision and accuracy of the point estimates and associated CIs used to report the primary outcomes. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/full#CD009229-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009229-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early versus delayed radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.71, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Progression‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.45, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early versus delayed radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009229.pub3/references#CD009229-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009229.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009229-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009229-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009229-note-0001">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD009229-note-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD009229-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009229-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009229-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009229\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009229\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009229\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009229\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009229\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=l7AWCCEw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009229.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009229.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009229.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009229.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009229.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726204493"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009229.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726204500"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009229.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8df3ebedf431',t:'MTc0MDcyNjIwNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 